scispace - formally typeset
G

Gernot Marx

Researcher at RWTH Aachen University

Publications -  323
Citations -  8497

Gernot Marx is an academic researcher from RWTH Aachen University. The author has contributed to research in topics: Intensive care & Medicine. The author has an hindex of 39, co-authored 280 publications receiving 6266 citations. Previous affiliations of Gernot Marx include University of Liverpool & University of Jena.

Papers
More filters
Journal ArticleDOI

Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.

TL;DR: Two novel markers for AKI have been identified and validated in independent multicenter cohorts and are superior to existing markers, provide additional information over clinical variables and add mechanistic insight into AKI.
Journal ArticleDOI

Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study

TL;DR: In the German health-care system, in which hospital capacities have not been overwhelmed by the COVID-19 pandemic, mortality has been high for patients receiving mechanical ventilation, particularly for patients aged 80 years or older and those requiring dialysis, and has been considerably lower for patients younger than 60 years.
Journal ArticleDOI

Chemokine (C-C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury

TL;DR: Human livers of ALF patients requiring liver transplantation reveal increased CD68+ hepatic macrophage numbers with massive infiltrates of periportal CCR2+ macrophages that display a proinflammatory polarization, and the pharmacological inhibition of either CCL2 or C CR2 might bear therapeutic potential by reducing the inflammatory reaction during the early phase of AILI.
Journal ArticleDOI

The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS.

TL;DR: This initial description of a cohort of COVID-19 patients with and without ARDS in Germany reveals that those with ARDS more commonly have preexisting respiratory diseases and obesity, as well as persistently elevated inflammatory markers.